← Back

Tianjin Tianyao Pharmaceuticals Co Ltd

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, betamethasone product series, and other hormone precursors. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It also exports its products to the United States, Southeast Asia, Asia, Europe, South America, Africa, and internationally. The company was founded in 1939 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.

Price · split & dividend adjusted
News & notes moving 600488.CG
600488.CG▲

Tianjin Pharmaceutical Subsidiary Hubei Tianjin Pharmaceutical Obtains Registration Certificate for Compound Electrolyte Injection

Tianjin Pharmaceutical announced that its subsidiary Hubei Tianjin Pharmaceutical has received the drug registration certificate for Compound Electrolyte Injection approved and issued by the National Medical Products Administration. The drug specification is 500ml, and the registration classification is chemical drug category 4. It can be used as a source of water and electrolyte replenishment and as an alkalizing agent. In October 2024, Hubei Tianjin Pharmaceutical submitted the registration and marketing application, which was accepted. As of the announcement date, the research and development investment was approximately 3.2 million yuan.
600488.CG ▲
Jiemian·24dRead more ▾
600488.CG▼

Nanning Tax Bureau Discloses False Invoicing Case Involving Five Prominent Pharmaceutical Companies Including Haisco and Tianjin Pharmaceuticals

The Nanning Tax Bureau recently disclosed that Nanning Huijiekang Marketing Services Company issued false ordinary VAT invoices to five downstream prominent pharmaceutical companies without actually providing any services, with a total price and tax amount of 7.338 million yuan. The companies involved include Tibet Haize Marketing Management Company, a holding subsidiary of the listed company Haisco, involving an amount of 1.2621 million yuan; Tianjin Jinyao Group Hubei Tianyao Pharmaceutical Company, a holding subsidiary of Tianjin Pharmaceuticals, involving an amount of 1 million yuan; as well as Shandong PKU High-Tech Huatai Pharmaceutical Company, Shandong Qidu Pharmaceutical Company, and Chengdu Better Pharmaceutical Company, involving amounts of 3.9 million yuan, 176,600 yuan, and 999,300 yuan respectively. All 84 invoices issued by Nanning Huijiekang were classified as false, and the company was deregistered in September 2022.
002653.CS ▼600488.CG ▼
红星资本局·25dRead more ▾
© 2026 MarketDXAsset